Nature Medicine, Published online: 07 February 2025; doi:10.1038/s41591-025-03495-zIn a first-in-human phase 1 trial, HER2-specific CAR macrophages were feasible to manufacture

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global nicotine patch market

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global wound closure

Healthcare Real Estate Insights™ magazine's national awards program honors multiple healthcare projects completed by PMB in 2024. SAN DIEGO, Feb.